Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 54.18-2.417.3270.7146.60

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 54.18 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202554.18
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 54.18
Positive
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,390.2 Cr -3.4% -1.1% -3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,497.0 Cr 1.1% -1.9% -14.1% Stock Analytics
DIVIS LABORATORIES ₹161,787.0 Cr 1.1% -0.6% 10.4% Stock Analytics
CIPLA ₹125,870.0 Cr -0.4% -0.4% -6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,591.0 Cr -1.7% -2.5% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,380.0 Cr 0.5% 4.1% -2.7% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3.4%

-1.1%

-3.7%

SENSEX

1.6%

2.3%

1.1%


You may also like the below Video Courses